Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6483571rdf:typepubmed:Citationlld:pubmed
pubmed-article:6483571lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0441833lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0014653lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0221102lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0038676lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0038744lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0038760lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C1373187lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:6483571lifeskim:mentionsumls-concept:C0075510lld:lifeskim
pubmed-article:6483571pubmed:issue4lld:pubmed
pubmed-article:6483571pubmed:dateCreated1984-11-20lld:pubmed
pubmed-article:6483571pubmed:abstractTextSulfisomidine, sulfamethomidine, sulfadimethoxine and their corresponding N4-acetyl derivatives were administered to man. The percentages of acetylation and deacetylation and those of protein binding, the half-lives of elimination and the apparent and true renal clearance values were measured. No acetylation phenotype could be demonstrated in these compounds. Methoxy substitution in the NI-pyrimidine group of sulfisomidine affects predominantly the renal clearance value and mechanism of the parent compound but has no influence on the renal clearance of the N4-acetyl derivatives. The renal clearance value of sulfisomidine is 232 +/- 33 ml/min, of sulfamethomidine 21.60 +/- 16.4 ml/min and of sulfadimethoxine 10.87 +/- 10.44 ml/min. The renal clearance values of the corresponding N4-acetylsulfonamide derivatives are 314 +/- 91 ml/min, 342 +/- 63 ml/min and 202 +/- 65 ml/min respectively. Tubular reabsorption, caused by methoxy substitution in the NI-pyrimidine ring, lowers the rate of elimination and increases the half-life. The half-life of sulfisomidine is 8.5 +/- 0.5 h, of sulfamethomidine 27.8 +/- 5.3 h and of sufadimethoxine 34.6 +/- 10.4 h.lld:pubmed
pubmed-article:6483571pubmed:languageenglld:pubmed
pubmed-article:6483571pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6483571pubmed:citationSubsetIMlld:pubmed
pubmed-article:6483571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6483571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6483571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6483571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6483571pubmed:statusMEDLINElld:pubmed
pubmed-article:6483571pubmed:monthAuglld:pubmed
pubmed-article:6483571pubmed:issn0167-6555lld:pubmed
pubmed-article:6483571pubmed:authorpubmed-author:VreeT BTBlld:pubmed
pubmed-article:6483571pubmed:authorpubmed-author:HeksterY AYAlld:pubmed
pubmed-article:6483571pubmed:authorpubmed-author:TijhuisM WMWlld:pubmed
pubmed-article:6483571pubmed:authorpubmed-author:TermondE FEFlld:pubmed
pubmed-article:6483571pubmed:authorpubmed-author:BaakmanMMlld:pubmed
pubmed-article:6483571pubmed:authorpubmed-author:OosterbaanM...lld:pubmed
pubmed-article:6483571pubmed:issnTypePrintlld:pubmed
pubmed-article:6483571pubmed:day24lld:pubmed
pubmed-article:6483571pubmed:volume6lld:pubmed
pubmed-article:6483571pubmed:ownerNLMlld:pubmed
pubmed-article:6483571pubmed:authorsCompleteYlld:pubmed
pubmed-article:6483571pubmed:pagination150-6lld:pubmed
pubmed-article:6483571pubmed:dateRevised2008-2-25lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:meshHeadingpubmed-meshheading:6483571-...lld:pubmed
pubmed-article:6483571pubmed:year1984lld:pubmed
pubmed-article:6483571pubmed:articleTitleEffects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.lld:pubmed
pubmed-article:6483571pubmed:publicationTypeJournal Articlelld:pubmed